Jci_page_head_homepage_01 Jci_page_head_homepage_02
Kiichiro Yano, Lawrence F. Brown, Michael Detmar
Published in Volume 107, Issue 4
J Clin Invest. 2001; 107(4):409–417 doi:10.1172/JCI11317
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 6

(a and b) Representative photomicrographs of hematoxylin-stained paraffin sections depict increased size of vibrissa follicles in 8-week-old VEGF transgenic mice (b), as compared with age-matched wild-type littermates (a). Scale bars = 100 μm. (c) Representative photomicrographs of mouse vibrissa organ cultures demonstrate absence of effects of VEGF treatment (V) on the in vitro hair growth rate, as compared with untreated controls (C1). Addition of 5% FBS (P), used as a positive control, resulted in a more than 15% increase in hair growth. Treatment with a neutralizing anti-VEGF antibody (Vab) did not influence in vitro hair growth, as compared with control antibody–treated follicles (C2). (d) Quantitative analysis demonstrates significant induction of in vitro hair growth by 5% FBS (P) (P < 0.001) but lack of efficiency of VEGF (V) or anti-VEGF antibody (Vab) treatment. Data are expressed as means ± SD. NS, no significant differences between the groups compared. AP < 0.001, two-sided unpaired Student’s t test.